Alum-ALM + BCG
Sponsors
Tehran University of Medical Sciences
Conditions
Healthy
Phase 2
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)
CompletedNCT00429780
Start: 2007-01-31End: 2007-12-31Target: 100Updated: 2009-11-18
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin
CompletedNCT00429715
Start: 2007-01-31End: 2007-12-31Target: 150Updated: 2011-02-17